Feitai, a Chinese herbal medicine, reduces transforming growth factor-β1 and monocyte chemoattractant protein-1 expression in bleomycin-induced lung fibrosis in mice

Clinical and Experimental Pharmacology and Physiology

Volumn 32, Issue 12, 2005, Pages 1071-1077

  Shen, Yun ^a,c   Zhao, Hao Long ^b   Du, Juan ^a   Li, Yu Ting ^a   Tan, Fang ^a   Huang, Cheng Gang ^b   Pei, Gang ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^c Shuguang Hospital Affiliated to Traditional Chinese Medicine University   (China)

Author keywords

Bleomycin; Feitai; Lung fibrosis; Mice; Monocyte chemoattractant protein 1; Transforming growth factor 1

Indexed keywords

BLEOMYCIN; CHINESE DRUG; CYTOKINE; FEITAI; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; SODIUM CHLORIDE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; CCL2 PROTEIN, MOUSE; HERBACEOUS AGENT; HYDROXYPROLINE; PEROXIDASE; TGFB1 PROTEIN, MOUSE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG MECHANISM; FEMALE; LUNG FIBROSIS; LUNG PARENCHYMA; MOUSE; NONHUMAN; PATHOGENESIS; PNEUMONIA; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL DIFFERENTIATION; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FIBROBLAST; IMMUNOHISTOCHEMISTRY; LUNG; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTI-BACTERIAL AGENTS; BLEOMYCIN; CELL DIFFERENTIATION; CHEMOKINE CCL2; DRUGS, CHINESE HERBAL; FEMALE; FIBROBLASTS; HYDROXYPROLINE; IMMUNOHISTOCHEMISTRY; LUNG; MICE; MICE, INBRED C57BL; PEROXIDASE; PULMONARY FIBROSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33644988235     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2005.04314.x     Document Type: Article

References (40)

1. Crough E. Pathobiology of pulmonary fibrosis. Am. J. Physiol. 1990 259 : L159 84.
2. Smith RE Strieter RM Zhang K et al. A role for C-C chemokines in fibrotic lung disease. J. Leukoc. Biol. 1995 57 : 782 5.
3. Piguet PF Collart MA Grau GE Sappino AP Vassalli P. Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis. Nature 1990 344 : 245 7.
4. Gharaee-Kermani M Phan SH. Role of cytokines and cytokine therapy in wound healing and fibrotic diseases. Curr. Pharm. Des. 2001 7 : 1083 103.
5. Kolb M Margetts PJ Anthony DC Pitossi F Gauldie J. Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis. J. Clin. Invest. 2001 107 : 1529 36.
6. Huanx F Liu T McGarry B Ullenbruch M Phan SH. Eosinophils and T lymphocytes possess distinct roles in bleomycin-induced lung injury and fibrosis. J. Immunol. 2003 170 : 2083 92.
7. Zhang K Gharaee-Kermani M Jones ML Warren JS Phan SH. Lung monocyte chemoattractant protein-1 gene expression in bleomycin-induced pulmonary fibrosis. J. Immunol. 1994 153 : 4733 41.
8. Betsuyaku T Fukuda Y Parks WC Shipley JM Senior RM. Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin. Am. J. Pathol. 2000 157 : 525 35.
9. Betsuyaku T Shipley JM Liu Z Senior RM. Neutrophil emigration in the lungs, peritoneum, and skin does not require gelatinase B. Am. J. Respir. Cell Mol. Biol. 1999 20 : 1303 9.
10. Snider GL Hayes JA Korthy AL. Chronic interstitial pulmonary fibrosis produced in hamsters by endotracheal bleomycin. Pathology and stereology. Am. Rev. Respir. Dis. 1978 117 : 1099 108.
11. Piguet PF Kaufman S Barazzone C Muller M Ryffel B Eugster HP. Resistance of TNF/LT alpha double deficient mice to bleomycin-induced fibrosis. Int. J. Exp. Pathol. 1997 78 : 43 6.
12. Phan SH Kunkel S. Lung cytokine production in bleomycin-induced pulmonary fibrosis. Exp. Lung Res. 1992 18 : 29 43.
13. Yao CF Jiang SL. Prevention and treatment of pulmonary-fibrosis by traditional Chinese medicine. Zhong Xi Yi Jie He Xue Bao 2003 1 : 234 8 (in Chinese).
14. Dai L Hou J Cai H. Using ligustrazini and Angelica sinensis to treat the bleomycin-induced pulmonary fibrosis in rats. Zhonghua Jie He He Hu Xi Za Zhi 1996 19 : 26 8 (in Chinese).
15. Xiao JH Zhang IH Chen HL Feng XL Wang JL. Inhibitory effects of isoliensinine on bleomycin-induced pulmonary fibrosis in mice. Planta Med. 2005 71 : 225 30.
16. Gong L-K Li X-H Wang H Zhang L Ren J. Feitai attenuates bleomycin-induced pulmonary fibrosis in rats. Biol. Pharm. Bull. 2004 27 : 634 40.
17. Iyonaga K Takeya M Saita N et al. Monocyte chemoattractant protein-1 in idiopathic pulmonary fibrosis and other interstitial lung diseases. Hum. Pathol. 1994 25 : 455 63.
18. Raghu G Masta S Meyers D Narayanan AS. Collagen synthesis by normal and fibrotic human lung fibroblasts and the effect of transforming growth factor-beta. Am. Rev. Respir. Dis. 1989 140 : 95 100.
19. Fine A Goldstein RH. The effect of transforming growth factor-beta on cell proliferation and collagen formation by lung fibroblasts. J. Biol. Chem. 1987 262 : 3897 902.
20. Gharaee-Kermani M Nozaki Y Hatano K Phan SH. Lung interleukin-4 gene expression in a murine model of bleomycin-induced pulmonary fibrosis. Cytokine 2001 15 : 138 47.
21. Zhang K Rekhter MD Gordon D Phan SH. Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study. Am. J. Pathol. 1994 145 : 114 25.
22. Iijima S Shou J Naama H Calvano SE Daly JM. Beneficial effect of enteral glycine in intestinal ischemia/reperfusion injury. J. Gastrointest. Surg. 1997 1 : 53 60.
23. Wossner JF. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch. Biochem. Biophys. 1961 93 : 440 7.
24. Ma J He B Li N Zhang H. Intervention by azithromycin on bleomycin-induced lung injury in rats and its mechanisms. Zhonghua Jie He He Hu Xi Za Zhi 2002 25 : 392 5 (in Chinese).
25. Varga J. Jimenez SA. Transforming growth factor beta (TGF beta) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts. Biochem. J. 1987 247 : 597 604.
26. Raghow R Postlethwaite AE Keski-Oja J Moses HL Kang AH. Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts. J. Clin. Invest. 1987 79 : 1285 8.
27. Sporn MB Roberts AB Wakerfield LM De Crombrugghe B. Some recent advances in the chemistry and biology of transforming growth factor-beta. J. Cell Biol. 1987 105 : 1039 45.
28. Pierce GF Mustoe TA Lingelbach J Masakowski VR Gramates P Deuel TF. Transforming growth factor β reverses the glucocorticoid-induced wound-healing deficit in rats: Possible regulation in macrophages by platelet-derived growth factor. Proc. Natl Acad. Sci. USA 1989 86 : 2229 33.
29. Hoyt DG Lazo JS. Alterations in pulmonary mRNA encoding procollagens, fibronectin and transforming growth factor-beta precede bleomycin-induced pulmonary fibrosis in mice. J. Pharmacol. Exp. Ther. 1988 246 : 765 71.
30. Raghow R Irish P HKang A. Coordinate regulation of transforming growth factor beta gene expression and cell proliferation in hamster lungs undergoing bleomycin-induced pulmonary fibrosis. J. Clin. Invest. 1989 84 : 1836 42.
31. Gurujeyalakshmi G Hollinger MA Girl SN. Regulation of transforming growth factor-beta1 mRNA expression by taurine and niacin in the bleomycin hamster model of lung fibrosis. Am. J. Respir. Cell Mol. Biol. 1998 18 : 334 42.
32. Roberts AB McCune BK Sporn MB. TGF-beta: Regulation of extracellular matrix. Kidney Int. 1992 41 : 557 9.
33. Breen E Shull S Burne S et al. Bleomycin regulation of transforming growth factor-beta mRNA in rat lung fibroblasts. Am. J. Respir. Cell Mol. Biol. 1992 6 : 146 52.
34. Girl SN Hyde DM Hollinger MA. Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice. Thorax 1993 48 : 959 66.
35. Antoniades HN Neville-Golden J Galanopoulos T Kradin RL Valente AJ Graves DT. Expression of monocyte chemoattractant protein-1 mRNA in human idiopathic pulmonary fibrosis. Proc. Natl Acad. Sci. USA 1992 89 : 5371 5.
36. Lyonaga K Takeya M Saita N et al. Monocyte chemoattractant protein-1 in idiopathic pulmonary fibrosis and other interstitial lung diseases. Hum. Pathol. 1994 25 : 455 63.
37. Chensue SW Warmington KS Ruth JH Sanghi PS Lincoln P Kunkel SL. Role of monocyte chemoattractant protein-1 (MCP-1) in Th1 (mycobacterial) and Th2 (schistosomal) antigen-induced granuloma formation: Relationship to local inflammation, Th cell expression, and IL-12 production. J. Immunol. 1996 157 : 4602 8.
38. Smith RE Strieter RM Phan SH Lukacs NW Huffnagle GB Wilke CA. A role for C-C chemokines in fibrotic lung disease. J. Leukoc. Biol. 1994 57 : 782 7.
39. Leonard EJ Yoshimura T. Human monocyte chemoattractant protein-1 (MCP-1). Immunol. Today 1990 11 : 97 101.
40. Gharaee-Kermani M Denholm EM Phan SH. Costimulatin of fibroblast collagen and transforming growth factor beta 1 gene expression by monocyte chemoattractant protein-1 via specific receptors. J. Biol. Chem. 1996 271 : 17 79 84.